The chairman of England’s Cancer Drugs Fund does not believe that it should have been set up and regrets that it has undermined the National Institute for Health and Care Excellence. So why did he take the job? “I got involved to sort it out,” Peter Clark, a consultant in oncology from Clatterbridge Centre for Oncology in northwest England, told a Westminster Health Forum seminar in London on 15 January.

For more details, go to: http://www.bmj.com/content/350/bmj.h270?etoc= [Subscription required]